Nasal juvenile angiofibroma: Current perspectives with emphasis on management

Fernando López*, Asterios Triantafyllou, Carl H. Snyderman, Jennifer L. Hunt, Carlos Suárez, Valerie J. Lund, Primož Strojan, Nabil F. Saba, Iain J. Nixon, Kenneth O. Devaney, Isam Alobid, Manuel Bernal–Sprekelsen, Ehab Y. Hanna, Alessandra Rinaldo, Alfio Ferlito

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

Juvenile angiofibroma is an uncommon, benign, locally aggressive vascular tumor. It is found almost exclusively in young men. Common presenting symptoms include nasal obstruction and epistaxis. More advanced tumors may present with facial swelling and visual or neurological disturbances. The evaluation of patients with juvenile angiofibroma relies on diagnostic imaging. Preoperative biopsy is not recommended. The mainstay of treatment is resection combined with preoperative embolization. Endoscopic surgery is the approach of choice in early stages, whereas, in advanced stages, open or endoscopic approaches are feasible in expert hands. Postoperative radiotherapy (RT) or stereotactic radiosurgery seem valuable in long-term control of juvenile angiofibroma, particularly those that extend to anatomically critical areas unsuitable for complete resection. Chemotherapy and hormone therapy are ineffective. The purpose of the present review was to update current aspects of knowledge related to this rare and challenging disease.

Original languageEnglish
Pages (from-to)1033-1045
Number of pages13
JournalHead and Neck
Volume39
Issue number5
DOIs
Publication statusPublished - 1 May 2017

Keywords / Materials (for Non-textual outputs)

  • embolization
  • endoscopy
  • juvenile nasopharyngeal angiofibroma
  • sinonasal tumors
  • surgery

Fingerprint

Dive into the research topics of 'Nasal juvenile angiofibroma: Current perspectives with emphasis on management'. Together they form a unique fingerprint.

Cite this